217 related articles for article (PubMed ID: 18373424)
1. Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth.
Hampel S; Kunze D; Haase D; Krämer K; Rauschenbach M; Ritschel M; Leonhardt A; Thomas J; Oswald S; Hoffmann V; Büchner B
Nanomedicine (Lond); 2008 Apr; 3(2):175-82. PubMed ID: 18373424
[TBL] [Abstract][Full Text] [Related]
2. Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death.
Arlt M; Haase D; Hampel S; Oswald S; Bachmatiuk A; Klingeler R; Schulze R; Ritschel M; Leonhardt A; Fuessel S; Büchner B; Kraemer K; Wirth MP
Nanotechnology; 2010 Aug; 21(33):335101. PubMed ID: 20657048
[TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
4. Surface chemistry dependent "switch" regulates the trafficking and therapeutic performance of drug-loaded carbon nanotubes.
Das M; Singh RP; Datir SR; Jain S
Bioconjug Chem; 2013 Apr; 24(4):626-39. PubMed ID: 23517108
[TBL] [Abstract][Full Text] [Related]
5. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
Chaudhuri P; Soni S; Sengupta S
Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
[TBL] [Abstract][Full Text] [Related]
6. Functionalized carbon nanotubes in drug design and discovery.
Prato M; Kostarelos K; Bianco A
Acc Chem Res; 2008 Jan; 41(1):60-8. PubMed ID: 17867649
[TBL] [Abstract][Full Text] [Related]
7. Diameter-dependent release of a cisplatin pro-drug from small and large functionalized carbon nanotubes.
Muzi L; Ménard-Moyon C; Russier J; Li J; Chin CF; Ang WH; Pastorin G; Risuleo G; Bianco A
Nanoscale; 2015 Mar; 7(12):5383-94. PubMed ID: 25727105
[TBL] [Abstract][Full Text] [Related]
8. Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics.
Panigrahi BK; Nayak AK
Curr Drug Deliv; 2020; 17(7):558-576. PubMed ID: 32384030
[TBL] [Abstract][Full Text] [Related]
9. [Study on the release and mechanism of carbon nanotubes loaded with verapamil hydrochloride in vitro].
Wang J; Wang YJ; Ran R; Liu YF; Zheng CL; Jiang LQ; Zhu JB
Zhong Yao Cai; 2012 Sep; 35(9):1500-7. PubMed ID: 23451507
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the research of carbon nanotubes as drug carriers].
Yu JG; Huang KL; Yang QQ; Liu SQ; Tang JC
Yao Xue Xue Bao; 2008 Oct; 43(10):985-91. PubMed ID: 19127860
[TBL] [Abstract][Full Text] [Related]
11. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery.
Chen ML; He YJ; Chen XW; Wang JH
Langmuir; 2012 Nov; 28(47):16469-76. PubMed ID: 23131026
[TBL] [Abstract][Full Text] [Related]
12. Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer.
Rieger C; Kunhardt D; Kaufmann A; Schendel D; Huebner D; Erdmann K; Propping S; Wirth MP; Schwenzer B; Fuessel S; Hampel S
Int J Pharm; 2015 Feb; 479(2):357-63. PubMed ID: 25595385
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanisms.
Erdmann K; Ringel J; Hampel S; Rieger C; Huebner D; Wirth MP; Fuessel S
Nanotechnology; 2014 Oct; 25(40):405102. PubMed ID: 25224682
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of carbon nanotubes into a gelatin-catechin conjugate: innovative approach for the preparation of anticancer materials.
Cirillo G; Vittorio O; Hampel S; Spizzirri UG; Picci N; Iemma F
Int J Pharm; 2013 Mar; 446(1-2):176-82. PubMed ID: 23428879
[TBL] [Abstract][Full Text] [Related]
15. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response.
Huang H; Yuan Q; Shah JS; Misra RD
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1332-9. PubMed ID: 21514336
[TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug.
Mahmood M; Karmakar A; Fejleh A; Mocan T; Iancu C; Mocan L; Iancu DT; Xu Y; Dervishi E; Li Z; Biris AR; Agarwal R; Ali N; Galanzha EI; Biris AS; Zharov VP
Nanomedicine (Lond); 2009 Dec; 4(8):883-93. PubMed ID: 19958225
[TBL] [Abstract][Full Text] [Related]
17. Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeutics.
Ringel J; Erdmann K; Hampel S; Kraemer K; Maier D; Arlt M; Kunze D; Wirth MP; Fuessel S
J Biomed Nanotechnol; 2014 Mar; 10(3):463-77. PubMed ID: 24730242
[TBL] [Abstract][Full Text] [Related]
18. Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.
Castro Nava A; Cojoc M; Peitzsch C; Cirillo G; Kurth I; Fuessel S; Erdmann K; Kunhardt D; Vittorio O; Hampel S; Dubrovska A
Int J Cancer; 2015 Nov; 137(10):2492-503. PubMed ID: 26059723
[TBL] [Abstract][Full Text] [Related]
19. The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment.
Shi J; Ma R; Wang L; Zhang J; Liu R; Li L; Liu Y; Hou L; Yu X; Gao J; Zhang Z
Int J Nanomedicine; 2013; 8():2361-73. PubMed ID: 23843694
[TBL] [Abstract][Full Text] [Related]
20. Carbon nanotubes for the delivery of therapeutic molecules.
Bianco A
Expert Opin Drug Deliv; 2004 Nov; 1(1):57-65. PubMed ID: 16296720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
